Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-10-064206
Filing Date
2010-12-01
Accepted
2010-12-01 09:18:27
Documents
2
Period of Report
2010-11-30

Document Format Files

Seq Description Document Type Size
1 v204321_6k.htm 6-K 25987
2 GRAPHIC logo.jpg GRAPHIC 10839
  Complete submission text file 0001144204-10-064206.txt   42443
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 101223617
SIC: 2834 Pharmaceutical Preparations